Pharmaceutical composition for treating HBsAg, HBeAg, and HBcAb test positive, HBsAg, HBeAb, and HBcAb test positive, liver cirrhosis and liver ascites

A technology for hepatic ascites and a composition is applied in the field of pharmaceutical compositions for the treatment of large and small yang, liver cirrhosis and hepatic ascites, which can solve the problems of complex pathogenesis, easy repetition, low functional performance, etc. The effect of blood circulation and enhancing immunity

Inactive Publication Date: 2020-11-10
古广雄
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] Hepatitis B is a virus in the viscera. The function of this disease is low, the pathogenesis is complicated, the course of the disease is long, it is easy to repeat, and it is affected by genetic medicine. Diseases caused by heat in the blood are difficult to cure. At present, there are many product

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] A pharmaceutical composition for treating three yang, liver cirrhosis and hepatic ascites, consisting of the following raw materials: Hedyotis diffusa 15g, Scutellaria barbata 15g, Shegan 15g, embroidery needle 25g, Polygonum cuspidatum 35g, Huangjizi 25g, Piercing stone 25g.

Embodiment 2

[0028] A pharmaceutical composition for treating three yang, liver cirrhosis and hepatic ascites, consisting of the following raw materials: Hedyotis diffusa 20g, Scutellaria barbata 20g, Shegan 20g, embroidery needle 30g, Polygonum cuspidatum 40g, Huangjizi 30g, Piercing stone 30g.

Embodiment 3

[0030] A pharmaceutical composition for treating three yang, liver cirrhosis and hepatic ascites, consisting of the following raw materials: Hedyotis diffusa 18g, Scutellaria barbata 18g, Shegan 18g, embroidery needle 27g, Polygonum cuspidatum 37g, Huangjizi 28g, Piercing stone 27g.

[0031] The clinical performance of the Chinese medicinal compound prepared by the present invention is illustrated below by clinical data:

[0032] 1. Observation of curative effect on the treatment of liver cirrhosis ascites

[0033] 1. General Information

[0034] 100 patients with liver cirrhosis and ascites, 50 males and 50 females, the youngest is 20 years old, the oldest is 65 years old, the average age is 42 years old, the disease course ranges from 14 months to 22 years, and the average disease course is 8 years.

[0035] 2. Diagnostic criteria

[0036]100 patients with liver cirrhosis and ascites were confirmed by ultrasound, liver function test, and CT examination. Serious complicati...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical composition for treating treating HBsAg, HBeAg, and HBcAb test positive, HBsAg, HBeAb, and HBcAb test positive, liver cirrhosis and liver ascites. The pharmaceutical composition is prepared from the following raw materials of 15-20 g of oldenlandia diffusa, 15-20 g of scutellaria barbata, 15-20 g of blackberry lily, 25-30 g of damnacanthus indicus, 35-40 gof polygonum cuspidatum, 25-30 g of gardenia jasminoides and 25-30 g of cudrania cochinchinensis. The pharmaceutical composition has the functions of promoting diuresis, removing jaundice, clearing away heat and toxic materials, promoting blood circulation, removing blood stasis, relieving pain, reducing phlegm, stopping coughing, promoting blood circulation, resisting cancer, killing bacteria, enhancing immunity and repairing normal liver metabolism.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a pharmaceutical composition for treating large and small three yang, liver cirrhosis and hepatic ascites. Background technique [0002] Liver cirrhosis is liver damage caused by a variety of reasons. The liver is progressive, diffuse, and fibrous. The specific manifestation is diffuse degeneration and necrosis of liver cells. Fibrous tissue hyperplasia and nodular regeneration of liver cells followed, and these three changes were repeated and interlaced, resulting in the gradual remodeling of the liver lobular structure and blood circulation pathways, causing the liver to deform and harden. In the later stage, complications such as portal hypertension, ascites, liver dysfunction, upper gastrointestinal bleeding, and hepatic coma appear, and the prognosis is poor. Cirrhotic ascites is a decompensated disease. The condition is complicated, the treatment is difficult, a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/88A61P1/16A61P31/20A61P7/10
CPCA61K36/539A61K36/60A61K36/704A61K36/74A61K36/744A61K36/748A61K36/88A61P1/16A61P7/10A61P31/20A61K2300/00
Inventor 古广雄
Owner 古广雄
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products